We found that murine tumour growth was inhibited in the radiotherapy group and the anti-CEACAM1 group compared with that in the isotype control group, whereas murine intracranial tumour volume shrank significantly in the combination therapy group with some mice experiencing even tumour dissipation (Fig. 2B). Here, CEACAM1 is linked to neoplasm.